​
​

NKGen Biotech Ownership | Who Owns NKGen Biotech?

OverviewChart

NKGen Biotech Ownership Summary

NKGen Biotech is owned by 31.65% institutional investors, and 68.35% retail investors. Gabelli Dividend & Income is the top mutual fund, with 1.30% of its assets in NKGen Biotech shares.

GFOR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNKGen Biotech31.65%-68.35%
SectorFinancial Services Stocks 43.55%12.63%43.82%
IndustryShell Companies Stocks 30.44%16.79%52.77%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202313-48.00%5,326,199-12.66%313.92%4-50.00%3-72.73%
Jun 30, 202325-53.70%6,098,503-62.35%280.50%8-38.46%1137.50%
Mar 31, 202354-11.48%16,198,5011.70%751.37%13-56.67%833.33%
Dec 31, 20226117.31%15,927,6208.97%741.60%3076.47%6-25.00%
Sep 30, 20225210.64%14,616,38615.68%681.96%1741.67%8700.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Gabelli Dividend & Income135.00K1.30%-10.00K
JPM Multi-Manager Alt C (acc) USD100.56K0.97%-
GAMCO Intl SICAV Merger Arbtrg I (USD)86.11K0.83%-
The Merger Fund A85.31K0.82%85.31K
RiverNorth Opportunities48.32K0.47%-
RiverNorth Marketplace Lending Corp22.30K0.21%-
Virtus Westchester Event-Driven Fd I9.19K0.09%9.19K
Karpus Tax Sensitive Fixed Income7.17K0.07%-
JNL Multi-Manager Alternative A4.36K0.04%-
JNL/Westchester Capital Event Driven A3.04K0.03%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 06, 2023Song Paul Y. Chief Executive OfficerBuy$250.00
Dec 07, 2023Song Paul Y. Chief Executive OfficerBuy$250.24
Dec 05, 2023Song Paul Y. Chief Executive OfficerBuy$350.22
Dec 04, 2023Song Paul Y. Chief Executive OfficerBuy$499.73
Dec 04, 2023Graf James A Interim CFOBuy$1.44K

Insider Transactions Trends

DateBuySell
2023 Q412-
2023 Q3--
2022 Q2--
2021 Q3--
2021 Q210-

GFOR Ownership FAQ

Who Owns NKGen Biotech?

NKGen Biotech shareholders are primarily institutional investors at 31.65%, followed by 0% insiders and 0% retail investors. The average institutional ownership in NKGen Biotech's industry, Shell Companies Stocks , is 30.44%, which NKGen Biotech exceeds.

Does Blackrock own NKGen Biotech?

BlackRock is not among the top 10 institutional shareholders of NKGen Biotech.

Who is the top mutual fund holder of NKGen Biotech shares?

Gabelli Dividend & Income is the top mutual fund holder of NKGen Biotech shares, with 1.30% of its total shares outstanding invested in 135K NKGen Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools